Valverde-Monge M, Sánchez-Carrasco P, Betancor D, et al.

Title: Comparison of long-term response and remission to omalizumab and anti-IL-5/IL-5R using different criteria in a real-life cohort of severe asthma patients.

Citation: Arch Broncoeneumol
2024;60:23–32.

Country: Spain | Indication: Asthma

This is an independent study

http://tago.ca/38042707
Scan to access the publication or visit
http://tago.ca/38042707